Sort

Search

01/06/2022 SELNET clinical practice guidelines for bone sarcoma
Blay, JY, Palmerini, E, Bollard, J, Aguiar, S, Angel, M, Araya, B, Badilla, R, Bernabeu, D, Campos, F, Caro-Sanchez, CHS, Montoya, AC, Casavilca-Zambrano, S, Castro-Oliden, V, Chacon, M, Clara-Altamirano, MA, Collini, P, Genoroso, RC, Costa, FD, Cuellar, M, Tos, APD, Malagon, HRD, Donati, DM, Dufresne, A, Eriksson, M, Farias-Loza, M, Frezza, AM, Frisoni, T, Garcia-Ortega, DY, Gerderblom, H, Gouin, F, Gomez-Mateo, MC, Gronchi, A, Haro, J, Hindi, N, Huanca, L, Jimenez, N, Karanian, M, Kasper, B, Lopes, A, David, BBL, Lopez-Pousa, A, Lutter, G, Maki, RG, Martinez-Said, H, Martinez-Tlahuel, JL, Mello, CA, Perez, JMM, Moura, DS, Nakagawa, SA, Nascimento, AG, Ortiz-Cruz, EJ, Patel, S, Pfluger, Y, Provenzano, S, Righi, A, Rodriguez, A, Santos, TG, Scotlandi, K, Silva, MLG, Soule, T, Stacchiotti, S, Valverde, CM, Waisberg, F, Estrada, EZ, Martin-Broto, J. SELNET clinical practice guidelines for bone sarcoma. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2022; 174DOI:10.1016/j.critrevonc.2022.103685. PMID:35460913. IF:6.200(Q1/3D).
01/06/2022 Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
Lindskog, M, Laurell, A, Kjellman, A, Melichar, B, Rey, PM, Zielinski, H, Villacampa, F, Bigot, P, Zoltan, B, Parikh, O, Alba, DV, Jellvert, D, Flasko, T, Gallardo, E, Caparros, MJR, Purkalne, G, Suenaert, P, Karlsson-Parra, A, Ljungberg, B. Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study. European Urology Open Science. 2022; 40DOI:10.1016/j.euros.2022.03.012. PMID:35638086. IF:2.500(Q3/6D).
01/06/2022 The spectrum of building block conformers sustains the biophysical properties of clinically-oriented self-assembling protein nanoparticles
Volta-Duran, E, Sanchez, JM, Hector-Lopez-Laguna, Parlade, E, Sanchez-Garcia, L, Sanchez-Chardi, A, de Marco, A, Unzueta, U, Vazquez, E, Villaverde, A. The spectrum of building block conformers sustains the biophysical properties of clinically-oriented self-assembling protein nanoparticles. Science China-Materials. 2022; 65(6)DOI:10.1007/s40843-021-1914-0. PMID:. IF:8.100(Q1/3D).
01/06/2022 Sarcoidosis following SARS-CoV-2 infection: Cause or consequence?
Palones, E, Pajares, V, Lopez, L, Castillo, D, Torrego, A. Sarcoidosis following SARS-CoV-2 infection: Cause or consequence?. Respirology Case Reports. 2022; 10(6)DOI:10.1002/rcr2.955. PMID:35505665. IF:(Q/D).
01/06/2022 The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours
Lopez, F, Shah, JP, Beitler, JJ, Snyderman, CH, Lund, V, Piazza, C, Makitie, AA, Guntinas-Lichius, O, Rodrigo, JP, Kowalski, LP, Quer, M, Shaha, A, Homma, A, Sanabria, A, Ferrarotto, R, Lee, AWM, Lee, VHF, Rinaldo, A, Ferlito, A. The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours. ADVANCES IN THERAPY. 2022; 39(6)DOI:10.1007/s12325-022-02080-x. PMID:35352310. IF:3.800(Q2/4D).
01/06/2022 A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper
Zozaya, N, Villaseca, J, Abdalla, F, Calleja, MA, Diez-Martin, JL, Estevez, J, Garcia-Sanz, R, Martinez-Lopez, J, Sierra, J, Vera, R, Hidalgo-Vega, A. A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper. Clinical & Translational Oncology. 2022; 24(6)DOI:10.1007/s12094-021-02757-9. PMID:34997475. IF:3.400(Q3/6D).
01/06/2022 Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk
Lopez, S, Martinez-Perez, A, Rodriguez-Rius, A, Vinuela, A, Brown, AA, Martin-Fernandez, L, Vilalta, N, Arus, M, Panousis, NI, Buil, A, Sabater-Lleal, M, Souto, JC, Dermitzakis, ET, Soria, JM. Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk. THROMBOSIS AND HAEMOSTASIS. 2022; 122(06)DOI:10.1055/s-0041-1742169. PMID:35272364. IF:6.700(Q1/2D).
01/06/2022 The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
Bazarbachi, A, Boumendil, A, Finel, H, Khvedelidze, I, Romejko-Jarosinska, J, Tanase, A, Akhtar, S, Ben Othman, T, Ma'koseh, M, Afanasyev, B, Cheikh, J, Briones, J, Gulbas, Z, Hamladji, RM, Elverdi, T, Blaise, D, Martinez, C, Alma, E, Halaburda, K, Sousa, AB, Glass, B, Robinson, S, Montoto, S, Sureda, A. The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years. LEUKEMIA. 2022; 36(6)DOI:10.1038/s41375-022-01563-8. PMID:35414657. IF:11.400(Q1/1D).
01/06/2022 Ocular involvement in patients with primary central-nervous-system lymphoma: Analysis of a multicentre study in Spain
Mercadal, S, Alana, M, Barcelo, MI, Bruixola, G, Lopez-Pereira, P, Bobillo, S, Dlouhy, I, Agud, RC, Molina, EG, Martinez, P, Cacabelos, P, Muntanola, A, Garcia-Catalan, G, Sancho, JM, Campos, I, Lado, T, Salar, A, Caballero, AC, Sole-Rodriguez, M, Velasco, R. Ocular involvement in patients with primary central-nervous-system lymphoma: Analysis of a multicentre study in Spain. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 197(6)DOI:10.1111/bjh.18148. PMID:35307813. IF:6.500(Q1/3D).
01/06/2022 Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (vol 57, pg 416, 2022)
Hernandez-Boluda, JC, Pereira, A, Zinger, N, Gras, L, Martino, R, Nikolousis, E, Finke, J, Chinea, A, Rambaldi, A, Robin, M, Saccardi, R, Natale, A, Snowden, JA, Tsirigotis, P, Vallejo, C, Wulf, G, Xicoy, B, Russo, D, Maertens, J, Daguindau, E, Lenhoff, S, Hayden, P, Czerw, T, McLornan, DP, Yakoub-Agha, I. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (vol 57, pg 416, 2022). BONE MARROW TRANSPLANTATION. 2022; 57(6)DOI:10.1038/s41409-022-01652-3. PMID:35361897. IF:4.800(Q1/2D).
01/06/2022 Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Onida, F, Sbianchi, G, Radujkovic, A, Sockel, K, Kroger, N, Sierra, J, Socie, G, Cornelissen, J, Poire, X, Raida, L, Bourhis, JH, Finke, J, Passweg, J, Salmenniemi, U, Schouten, HC, Beguin, Y, Martin, S, Deconinck, E, Ganser, A, Zver, S, Lioure, B, Rohini, R, Koster, L, Hayden, P, Iacobelli, S, Robin, M, Yakoub-Agha, I. Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP. BONE MARROW TRANSPLANTATION. 2022; 57(6)DOI:10.1038/s41409-021-01555-9. PMID:35352038. IF:4.800(Q1/2D).
01/06/2022 The EHA Research Roadmap: Malignant Lymphoid Diseases
Dreyling, M, Andre, M, Gokbuget, N, Tilly, H, Jerkeman, M, Gribben, J, Ferreri, A, Morel, P, Stilgenbauer, S, Fox, C, Ribera, JM, Zweegman, S, Aurer, I, Bodor, C, Burkhardt, B, Buske, C, Caballero, MD, Campo, E, Chapuy, B, Davies, A, de Leval, L, Doorduijn, J, Federico, M, Gaulard, P, Gay, F, Ghia, P, Gronbaek, K, Goldschmidt, H, Kersten, MJ, Kiesewetter, B, Landman-Parker, J, Le Gouill, S, Lenz, G, Leppa, S, Lopez-Guillermo, A, Macintyre, E, Mantega, MVM, Moreau, P, Moreno, C, Nadel, B, Okosun, J, Owen, R, Pospisilova, S, Pott, C, Robak, T, Spina, M, Stamatopoulos, K, Stary, J, Tarte, K, Tedeschi, A, Thieblemont, C, Trappe, RU, Trumper, LH, Salles, G. The EHA Research Roadmap: Malignant Lymphoid Diseases. Hemasphere. 2022; 6(6)DOI:10.1097/HS9.0000000000000726. PMID:35620592. IF:6.600(Q1/3D).
01/06/2022 Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
Waszczuk-Gajda, A, Penack, O, Sbianchi, G, Koster, L, Blaise, D, Remenyi, P, Russell, N, Ljungman, P, Trneny, M, Mayer, J, Iacobelli, S, Kobbe, G, Scheid, C, Apperley, J, Touzeau, C, Lenhoff, S, Jantunen, E, Anagnostopoulos, A, Paris, L, Browne, P, Thieblemont, C, Schaap, N, Sierra, J, Yakoub-Agha, I, Garderet, L, Styczynski, J, Schoemans, H, Moiseev, I, Duarte, RF, Peric, Z, Montoto, S, van Biezen, A, Mikulska, M, Aljurf, M, Ruutu, T, Kroger, N, Morris, C, Koenecke, C, Schoenland, S, Basak, GW. Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study. Journal of Clinical Medicine. 2022; 11(12)DOI:10.3390/jcm11123541. PMID:35743620. IF:3.900(Q2/4D).
01/06/2022 Dual-Stentriever technique for retrieval of an unusual middle cerebral artery embolus
Martínez González, J.P., Guerrero Vara, R., Medina Iglesias, V., Branera Pujol, J., Camps Renom, P.. Dual-Stentriever technique for retrieval of an unusual middle cerebral artery embolus. NEUROLOGIA. 2022; 37(5)DOI:10.1016/j.nrl.2021.08.006. PMID:34509320. IF:3.900(Q1/3D).
01/06/2022 A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4(+) lymphoma cells without toxicity in immunocompromised and immunocompetent mice
Falgàs A., Garcia-León A., Núñez Y., Serna N., Sánchez-Garcia L., Unzueta U., Voltà-Durán E., Aragó M., Álamo P., Alba-Castellón L., Sierra J., Gallardo A., Villaverde A., Vázquez E., Mangues R., Casanova I.. A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4(+) lymphoma cells without toxicity in immunocompromised and immunocompetent mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 150DOI:10.1016/j.biopha.2022.112940. PMID:35421785. IF:7.500(Q1/1D).
01/06/2022 Gulls living in cities as overlooked seed dispersers within and outside urban environments
Martin-Velez, V, Montalvo, T, Afan, I, Sanchez-Marquez, A, Aymi, R, Figuerola, J, Lovas-Kiss, A, Navarro, J. Gulls living in cities as overlooked seed dispersers within and outside urban environments. The Science of the total environment. 2022; 823DOI:10.1016/j.scitotenv.2022.153535. PMID:35104514. IF:9.800(Q1/1D).
01/06/2022 Erythematous Facial Plaques With an Unfavorable Course
Tubau C., Amat-Samaranch V., Flores-Climente V.. Erythematous Facial Plaques With an Unfavorable Course. Actas Dermo-Sifiliograficas. 2022; 113(6)DOI:10.1016/j.ad.2021.01.013. PMID:. IF:(Q/D).
31/05/2022 Gender Differences in Takotsubo Syndrome
Arcari, L, Nunez-Gil, IJ, Stiermaier, T, El-Battrawy, I, Guerra, F, Novo, G, Musumeci, B, Cacciotti, L, Mariano, E, Caldarola, P, Parisi, G, Montisci, R, Vitale, E, Sclafani, M, Volpe, M, Corbi-Pasqual, M, Martinez-Selles, M, Almendro-Delia, M, Sionis, A, Uribarri, A, Akin, I, Thiele, H, Brunetti, ND, Eitel, I, Santoro, F. Gender Differences in Takotsubo Syndrome. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022; 79(21)DOI:10.1016/j.jacc.2022.03.366. PMID:35618345. IF:24.000(Q1/1D).
31/05/2022 About the Need for Recognition of so-called Core Professional Groups within genetic Health Care in Europe
Paneque, M, Juhe, CS, Melegh, B, Carreira, I, Moog, U, Liehr, T. About the Need for Recognition of so-called Core Professional Groups within genetic Health Care in Europe. Medizinische Genetik. 2022; 34(1)DOI:10.1515/medgen-2022-2116. PMID:. IF:1.100(Q4/10D).
30/05/2022 Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't
Ong, ACM, Torra, R. Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't. Clinical Kidney Journal. 2022; 15(6)DOI:10.1093/ckj/sfac103. PMID:35664267. IF:4.600(Q1/2D).